Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Source: SeekingAlpha
2026-04-20 11:55:48 ET
More on Health Care stocks
- IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech
- Routine Vaccines Okay For Now: Investment Implications Of The Court Decision
- Sector Rotation: Healthcare XLV Should Be The Next Stop
- Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
- Notable healthcare headlines for the week: J&J, Abbott and Organon in focus
Read the full article on Seeking Alpha
For further details see:
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Apellis Pharmaceuticals Inc.
NASDAQ: APLS
APLS Trading
-0.01% G/L:
$41.04 Last:
5,223,027 Volume:
$41.05 Open:
APLS Latest News
May 07, 2026 06:01:00 pm
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
APLS Stock Data
$2,869,591,944
89,501,409
1.5%
87
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
